How to Buy Eagle Pharmaceuticals Stock
Eagle Pharmaceuticals Inc
Eagle Pharmaceuticals, Inc. , a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States.
Eagle Pharmaceuticals stock last closed at $4.16, down 1.89% from the previous day, and has decreased 84.98% in one year. It has underperformed other stocks in the Drug Manufacturers - Specialty & Generic industry by 0.78 percentage points. Eagle Pharmaceuticals stock is currently +2.72% from its 52-week low of $4.05, and -86.32% from its 52-week high of $30.40.
There are currently 12.99M EGRX shares outstanding. The market capitalization of EGRX is $54.03M. In the last 24 hours, 79,708 EGRX shares were traded.
How to Buy Eagle Pharmaceuticals Stock
Not sure how to invest in Eagle Pharmaceuticals stock? Here's how.
- Decide where to buy Eagle Pharmaceuticals stock: You need to choose a stock brokerage, but don't worry - we've researched dozens of stock brokerages and apps to help you determine where to buy Eagle Pharmaceuticals stock.
- Sign up for your brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've identified.
- Deposit funds into your brokerage account: Pick your method of payment and add your information.
- Evaluate Eagle Pharmaceuticals stock: The Eagle Pharmaceuticals ticker symbol is EGRX. Is Eagle Pharmaceuticals stock a good investment? Should you buy shares of EGRX? How do EGRX's underlying business fundamentals look? Do top analysts think Eagle Pharmaceuticals is a good buy? Why has EGRX's stock price moved recently? (Hint: Our stock research website can help you decide if EGRX is a good stock to buy).
- Make your EGRX purchase: Decide if you will purchase EGRX shares at the current market price or use a limit order to buy EGRX stock at a given price.
- Get the latest news on your investment in EGRX: Create a watchlist to keep tabs on your new investment in Eagle Pharmaceuticals stock.
Step 1: Decide where to buy Eagle Pharmaceuticals stock
You need an online brokerage account in order to access the NASDAQ market and buy EGRX shares.
Our preferred brokerage: eToro
Based on our analysis, eToro is the best online stock brokerage. eToro gives you:
- Invest in stocks with zero commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still buy the stock.
- Access to world markets: From Technology to Healthcare, New York to London — you can fill your portfolio with stocks from the world's top stock exchanges.
- Social investing: eToro boasts a community of more than 20 million users globally. Talk to, learn from, and copy the crypto trades of other investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other financial assets: Such as ETFs and cryptos.
Get $10 towards your purchase of shares by opening an account with eToro now.
Open eToro AccountStep 2: Sign up for your brokerage account
Now that you've selected your brokerage, you'll need to fill out some personal info so you can invest in EGRX stock today.
How to Start a New Brokerage Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Provide your personal info to start a new brokerage account.
- Submit your details by pressing the "Create Account" button. Get started with eToro today
Step 3: Deposit funds into your brokerage account
Now that you've created your account on one of the most highly reviewed stock trading apps, your next step is to transfer the money for your investment:
Check out the video below if you need help transferring money into your new brokerage account.
Step 4: Evaluate Eagle Pharmaceuticals stock
After you have decided on the best place to buy Eagle Pharmaceuticals stock, it's important to evaluate their stock prior to investing, so you actually comprehend the risk and upside.
Eagle Pharmaceuticals quick stats
Fundamentals of EGRX
WallStreetZen was created to help average investors do better fundamental analysis quickly.
You can see all of the due diligence checks on EGRX's stock page.
What is the fair value of EGRX stock?
Investors use a variety of different financial metrics, analyses, models, and charts to gauge EGRX's fair value.
Using relative valuations ratios:
- EGRX may be undervalued based on its P/E ratio of 4.52x, relative to Drug Manufacturers - Specialty & Generic industry P/E ratio of 33.92x
- EGRX could be undervalued based on its P/B ratio of 0.21x, relative to Drug Manufacturers - Specialty & Generic industry P/B ratio of 2.09x
You can do additional valuation research on EGRX's stock here.
A quick look at EGRX Financials
Signs that EGRX is financially healthy:
- There are more short-term assets than short-term liabilities on the EGRX balance sheet.
- EGRX has cash burn of 9392000. It has enough cash and short-term investments to cover this for at least one year.
- There are more short-term assets than long-term liabilities on the EGRX balance sheet.
- EGRX has $15.35M in cash and short term investments. This is enough to cover its annual cash burn of $9.39M.
Signs that EGRX is not financially healthy:
- EGRX has a relatively high debt to equity ratio of 0.61.
- EGRX profit margin has gone down from 8.4% to 4.6% in the past year.
- Total EGRX debt is higher than 5 years ago, relative to shareholder equity.
You can dive deeper into what analysts are projecting on the Eagle Pharmaceuticals stock forecast page.
EGRX Trading Indicators
EGRX Earnings
Last year, EGRX earnings were $11.95M. During the past 5 year, EGRX's earnings have grown by -14.47% per year. This was slower than the Drug Manufacturers - Specialty & Generic industry average of -9.47%.
Last year, EGRX revenue was $257.55M. In the past five year, EGRX's revenue has increased by 3.61% per year. This was slower than the Drug Manufacturers - Specialty & Generic industry average of 30.65%.
You can analyze EGRX's earnings and revenue performance here.
Are EGRX insiders buying or selling the stock?
Over the past year, insiders at EGRX have sold more shares than they have bought.
Scott Tarriff, 10% Owner of EGRX, was the latest EGRX insider to sell. They sold $13,286.13 worth of EGRX stock on Feb 28, 2024.
Research more about who owns EGRX stock here.
Does EGRX provide a stable income stream?
No, Eagle Pharmaceuticals doesn't provide an income stream by paying out dividends.
EGRX Social Trading Data
One of the reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to find out what other investors have to say.
Step 5: Make your EGRX purchase
You have two main types of orders:
- Market order: A market order is an order to buy or sell a security at the best price on the market.
Market orders are usually sufficient. - Limit order: A limit order enables you to buy or sell a stock at a specific price (or better).
If you want to ensure you're buying or selling at an exact price, place a limit order.
Hit the Open button and eToro will execute the order.
If you need more assistance buying stocks on eToro, click the how to video below:
Step 6: Get the latest news on your investment in EGRX
Now that you own some EGRX stock, you'll want to keep up with your shares.
Make a watchlist to get notified of important updates regarding your EGRX stock.
EGRX Feed
How to Buy Stock in Eagle Pharmaceuticals
To reiterate, here are the 6 steps you need to take to buy Eagle Pharmaceuticals stock right now:
- Decide where to buy Eagle Pharmaceuticals stock
- Sign up for your brokerage account
- Deposit funds into your brokerage account
- Evaluate Eagle Pharmaceuticals stock
- Make your EGRX purchase
- Get the latest news on your investment in EGRX
If you are looking for a brokerage account, eToro is our recommended option.
Get Started with eToro TodayIf you want to get updates on your investment in Eagle Pharmaceuticals, hit the button below to create your watchlist.
Related Articles
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.